WTC
CRL icon

WhitTier Trust Company’s Charles River Laboratories CRL Stock Holding History

WhitTier Trust Company’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.26K Sell
23
-1
-4% -$178 ﹤0.01% 1166
2026
Q1 		$4.04K Buy
24
+11
+85% +$2.04K ﹤0.01% 1177
2025
Q4 		$2.81K Hold
13
– – ﹤0.01% 1147
2025
Q3 		$2.31K Buy
13
+2
+18% +$318 ﹤0.01% 1161
2025
Q2 		$1.67K Sell
11
-275
-96% -$36.7K ﹤0.01% 1328
2025
Q1 		$43K Hold
286
– – ﹤0.01% 813
2024
Q4 		$52.8K Buy
286
+7
+3% +$1.35K ﹤0.01% 744
2024
Q3 		$55K Sell
279
-2
-0.7% -$416 ﹤0.01% 728
2024
Q2 		$58K Buy
281
+193
+219% +$43.7K ﹤0.01% 670
2024
Q1 		$23.8K Hold
88
– – ﹤0.01% 829
2023
Q4 		$20.8K Sell
88
-12
-12% -$2.36K ﹤0.01% 832
2023
Q3 		$19.6K Sell
100
-152
-60% -$31.2K ﹤0.01% 817
2023
Q2 		$53K Buy
252
+5
+2% +$995 ﹤0.01% 658
2023
Q1 		$49.8K Hold
247
– – ﹤0.01% 663
2022
Q4 		$53.8K Sell
247
-8,901
-97% -$1.94M ﹤0.01% 655
2022
Q3 		$1.8M Buy
9,148
+613
+7% +$132K 0.08% 208
2022
Q2 		$1.83M Buy
8,535
+602
+8% +$147K 0.08% 211
2022
Q1 		$2.25M Buy
7,933
+1,934
+32% +$596K 0.08% 196
2021
Q4 		$2.26M Buy
5,999
+664
+12% +$258K 0.08% 191
2021
Q3 		$2.2M Buy
5,335
+235
+5% +$97.6K 0.09% 189
2021
Q2 		$1.89M Buy
5,100
+113
+2% +$37.7K 0.08% 198
2021
Q1 		$1.45M Buy
4,987
+503
+11% +$140K 0.06% 215
2020
Q4 		$1.12M Buy
4,484
+410
+10% +$97.6K 0.06% 229
2020
Q3 		$923K Buy
+4,074
New +$845K 0.05% 232

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

WhitTier Trust Company's CRL Position: Q2 2026 in Review

WhitTier Trust Company reduced its Charles River Laboratories (CRL) stake by 4.2% in Q2 2026, selling an estimated $178 and leaving 23 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

WhitTier Trust Company first reported a position in CRL in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.26M in Q4 2021. 232 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • WhitTier Trust Company held 23 shares of Charles River Laboratories worth $5.26K as of Q2 2026.
  • WhitTier Trust Company sold 1 Charles River Laboratories share in Q2 2026, an estimated $178.
  • Charles River Laboratories made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1166 holding.
  • WhitTier Trust Company first reported a position in Charles River Laboratories in Q3 2020 and has held it in 24 quarters since.
  • WhitTier Trust Company's Charles River Laboratories position peaked at $2.26M in Q4 2021.
  • 232 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.